Management of Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma.
Crago AM, Cardona K, Koseła-Paterczyk H, Rutkowski P.
Surg Oncol Clin N Am. 2022 Jul;31(3):419-430. doi: 10.1016/j.soc.2022.03.006.
Undifferentiated Pleomorphic Sarcoma.
Robles-Tenorio A, Solis-Ledesma G.
2023 Apr 10. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Comparison of Features and Outcomes of Undifferentiated Pleomorphic Sarcoma of Bone and Soft Tissue.
Gusho CA, Lee L, Guntin J, Blank AT.
J Surg Res. 2022 Feb;270:313-320. doi: 10.1016/j.jss.2021.09.032. Epub 2021 Oct 29.
Predicting the prognosis of undifferentiated pleomorphic soft tissue sarcoma: a 20-year experience of 266 cases.
Vodanovich DA, Spelman T, May D, Slavin J, Choong PFM.
ANZ J Surg. 2019 Sep;89(9):1045-1050. doi: 10.1111/ans.15348. Epub 2019 Jul 30.
Soft-Tissue Sarcomas of the Abdomen and Pelvis: Radiologic-Pathologic Features, Part 2-Uncommon Sarcomas.
Levy AD, Manning MA, Miettinen MM.
Radiographics. 2017 May-Jun;37(3):797-812. doi: 10.1148/rg.2017160201.
Review of primary superficial soft tissue mesenchymal tumors of malignant or intermediate biological potential.
Oettel DJ, Bernard SA.
Skeletal Radiol. 2023 Mar;52(3):435-445. doi: 10.1007/s00256-022-04127-0. Epub 2022 Jul 22.
Reconstruction of upper limb soft-tissue defects after sarcoma resection with free flaps: A systematic review.
Lucattelli E, Lusetti IL, Cipriani F, Innocenti A, De Santis G, Innocenti M.
J Plast Reconstr Aesthet Surg. 2021 Apr;74(4):755-767. doi: 10.1016/j.bjps.2020.10.065. Epub 2020 Nov 8.
UNDIFFERENTIATED PLEOMORPHIC SARCOMA: PROGNOSTIC FACTORS IN 42 EXTREMITY CASES.
Maçaneiro CH, Baptista AM, Camargo OP, Filippi RZ, Oliveira ET.
Acta Ortop Bras. 2023 May 1;31(2):e265942. doi: 10.1590/1413-785220233102e265942. eCollection 2023.
Single-cell and spatial transcriptomics identify COL6A3 as a prognostic biomarker in undifferentiated pleomorphic sarcoma.
Klein JC, Wang L, Strand D, Lastufka C, Hosler GA, Hon GC.
Mol Cancer. 2024 Nov 15;23(1):257. doi: 10.1186/s12943-024-02168-8.
Undifferentiated pleomorphic sarcoma: Factors predictive of adverse outcomes.
Winchester D, Lehman J, Tello T, Chimato N, Hocker T, Kim S, Chang J, Markey J, Yom SS, Ryan W, Mully T, Hodge D, Otley C, Arron ST.
J Am Acad Dermatol. 2018 Nov;79(5):853-859. doi: 10.1016/j.jaad.2018.05.022. Epub 2018 May 19.
